Abstract
There is currently considerable interest in the stereochemical aspects of biochemical pharmacology, largely originating from analytical developments permitting the determination of the enantiomeric composition of chiral drugs in biological media. These new methods allow new types of experiments to be carried out, but there is a need for them to be used critically: a number of pitfalls await those who use them inappropriately. These particularly present themselves in metabolic studies where authentic standards are not available for method validation. Both of the major methods for determining enantiomeric composition can give rise to errors. The formation of diastereoisomers may exhibit stereoselectivity, while the use of chiral columns is fraught with difficulties. In both cases, calibration lines for the two enantiomers are frequently different. Additionally, enantiodifferentiation may occur during sample work-up, as a consequence of achiral processes such as solvent extraction. The importance of proper method validation, with each of a pair of enantiomers, cannot be stressed too highly. If standards of appropriate enantiomeric purity are not available, individual methods cannot be acceptably validated, and data can be accepted only when the same result is obtained with two methods relying on different principles, e.g. a chiral column plus a diastereomeric derivatization, or a Chromatographic method plus NMR.⊗
This Forum Abstract has been married up with a provisional text MS., without a proof-correcting stage.-Editor.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Beckett, A.H. & Casy, A.F. (1954) Nature 173, 1231–1232.
Beckett, A.H. & Casy, A.F. (1955) J. Pharm. Pharmacol. 6, 986–999.
Smith, R.L. & Caldwell, J. (1988), in course of publication.
Ariëns, E.J. (1987) Med. Res. Rev. 7, 367–387.
Tsai, W.L., Hermann, K., Hug, E., Rhode, B. & Dreiding, A.S. (1985) Helv. Chim. Acta 68, 2238–2243.
Adams, J.D. jr., Woolf, T.F., Trevor, A.J., Williams, L.R. & Castagnoli, N. jr. (1982) J. Pharm. Sci. 71, 658–661.
Hutt, A.J., Fournel, S. & Caldwell, J. (1986) J. Chromatog. 378, 409–418.
Testa, B. (1986) Xenobiotica 16, 265–269.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Caldwell, J., Derbyshire, J.F., Winter, S.M., Hutt, A.J. (1988). Pitfalls in the Enantioselective Analysis of Chiral Drugs. In: Reid, E., Robinson, J.D., Wilson, I.D. (eds) Bioanalysis of Drugs and Metabolites, Especially Anti-Inflammatory and Cardiovascular. Methodological Surveys in Biochemistry and Analysis, vol 18 A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9424-3_33
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9424-3_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9426-7
Online ISBN: 978-1-4757-9424-3
eBook Packages: Springer Book Archive